Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Correction for 'Enhanced photothermal-ferroptosis effects based on RBCm-coated PDA nanoparticles for effective cancer therapy' by Hongli Yu , , 2023, , 415-429, https://doi.org/10.1039/D2TB02329F.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1039/d5tb90131f | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Correction: Enhanced photothermal-ferroptosis effects based on RBCm-coated PDA nanoparticles for effective cancer therapy.
J Mater Chem B
August 2025
Department of Pharmaceutics, School of Pharmacy, Qingdao University, Qingdao 266021, China.
Correction for 'Enhanced photothermal-ferroptosis effects based on RBCm-coated PDA nanoparticles for effective cancer therapy' by Hongli Yu , , 2023, , 415-429, https://doi.org/10.1039/D2TB02329F.
View Article and Find Full Text PDFFlexible Microneedle Platform for Synergistic Chemo/Photothermal Ferroptosis Therapy via P-Glycoprotein Inhibition in Breast Cancer.
ACS Appl Mater Interfaces
July 2025
School of Food and Pharmacy, Zhejiang Ocean University, Zhoushan 316022, PR China.
Combining photothermal therapy (PTT) with chemotherapy shows promise for cancer treatment, but its efficacy is limited by heat shock protein (HSP)-induced thermoresistance and P-glycoprotein (P-gp)-mediated drug efflux. To overcome these challenges, we developed a tumor microenvironment-responsive microneedle platform for synergistic chemotherapy, PTT, and ferroptosis in breast cancer. The system employs Fe-coordinated dihydromyricetin (DMY) nanocarriers encapsulating doxorubicin (DMFD NPs) integrated into a flexible polyvinylpyrrolidone (PVP) microneedle patch.
View Article and Find Full Text PDFA Ferrocene-Based Supramolecular Photothermal Agent for Enhanced Photothermal/Ferroptosis Therapy and Immune Activation.
Biomacromolecules
August 2025
Shanghai Key Laboratory of Functional Materials Chemistry, East China University of Science and Technology, Shanghai 200237, China.
Photothermal therapy (PTT) is impeded by limited light penetration depth and cellular heat resistance induced by overexpressed heat shock proteins. Herein, we propose a ferrocene (Fc)-based supramolecular photothermal agent (PTA) to improve the therapeutic efficacy. Cy-Fc/CD-PEG not only had excellent photothermal effect but also possessed the ability to induce ferroptosis and immunotherapy.
View Article and Find Full Text PDFNIR-responsive CuSe@Fc nanoparticles for photothermal- ferroptosis combination therapy in esophageal cancer.
J Nanobiotechnology
May 2025
School of Materials Science and Engineering, The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology, Luoyang, 471023, China.
Esophageal cancer (EC) represents a highly recurrent and aggressive malignancy within the digestive system. However, conventional therapeutic strategies exhibit notable limitations in their clinical applications. Photothermal therapy (PTT), combined with ferroptosis, has attracted considerable attentions, emerging as a promising novel strategy for EC treatment.
View Article and Find Full Text PDFA cascaded amplification carrier-free nanoplatform for synergistic photothermal/ferroptosis therapy dual antioxidant pathway disruption in cervical cancer.
J Mater Chem B
May 2025
School of Chemistry and Chemical Engineering, Southeast University, Nanjing 210089, P. R. China.
Cellular defense mechanisms against ferroptosis are primarily mediated by antiferroptotic regulators, particularly glutathione peroxidase 4 (GPX4) and ferroptosis suppressor protein 1 (FSP1). Notably, singlet oxygen (O) generated through photoactivation of organic small-molecule photosensitizers (PSs) has been demonstrated to deplete both glutathione (GSH) and nicotinamide adenine dinucleotide phosphate (NADPH). This dual depletion mechanism effectively disrupts the GSH/GPX4 redox axis and the NADPH/FSP1/ubiquinone (CoQ) antioxidant system, thereby potentiating ferroptosis.
View Article and Find Full Text PDF